Found 2 bookmarks
Custom sorting
A recent study showed an extended risk of a major adverse cardiac event three years following a Covid infection. This is different from previous studies showing a tapering of risk over time. AB blood types showed an increased risk as well. Erica Spatz MD🧵
A recent study showed an extended risk of a major adverse cardiac event three years following a Covid infection. This is different from previous studies showing a tapering of risk over time. AB blood types showed an increased risk as well. Erica Spatz MD🧵
“A recent study showed an extended risk of a major adverse cardiac event three years following a Covid infection. This is different from previous studies showing a tapering of risk over time. AB blood types showed an increased risk as well. Erica Spatz MD🧵”
·x.com·
A recent study showed an extended risk of a major adverse cardiac event three years following a Covid infection. This is different from previous studies showing a tapering of risk over time. AB blood types showed an increased risk as well. Erica Spatz MD🧵
COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type | Arteriosclerosis, Thrombosis, and Vascular Biology
COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type | Arteriosclerosis, Thrombosis, and Vascular Biology

COVID-19 significantly raises the risk of major adverse cardiac events, including myocardial infarction and stroke, especially in hospitalized patients.

The risk of thrombotic events is higher in individuals with non-O blood types.

“The risk of MACE (major adverse cardiac events)was elevated in COVID-19 cases at all levels of severity”

The risk of MACE was elevated in COVID-19 cases at all levels of severity
·ahajournals.org·
COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type | Arteriosclerosis, Thrombosis, and Vascular Biology